{"nct_id":"NCT02787005","title":"Study of Pembrolizumab (MK-3475) in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)(MK-3475-199/KEYNOTE-199)","status":"COMPLETED","status_verified_date":"2024-11","start_date":"2016-07-01","start_date_type":"ACTUAL","primary_completion_date":"2022-02-28","primary_completion_date_type":"ACTUAL","completion_date":"2022-02-28","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["MRK"]}